Start-up Signatur Biosciences launched

We are excited to announce the launch of Signatur Biosciences, commercialising smart PCR kits based on our innovative PCRchitectureplatform.

We have re-engineered the PCR molecular machinery, empowering it to process the information from multiple RNA biomarkers simultaneously. This provides for a fast and simple diagnostic tool, even for complex multifactorial conditions.

Read more about the company and the technology behind it.

Top Image: the founders of Signature Bioscience: Dr. John Goertz, CSO; Celestin de Wergifosse, CEO; Prof. Molly Stevens, non-executive director.